Helen I. Field

6.4k citations

29 papers · 2.3k indexed · h-index 22

Co-authors: Ryuji Hamamoto Yusuke Nakamura Shinya Hayami Mark C. Field Bruce A.J. Ponder Masanori Yoshimatsu David E. Neal Tatsuhiko Tsunoda
Topics: Epigenetics and DNA Methylation (10 papers)Trypanosoma species research and implications (10 papers)Cancer-related gene regulation (9 papers)
Cited by: Physiology Molecular Biology Cancer Research
Journals: Journal of Biological Chemistry Nature Communications Cancer Research
Partner nations: United Kingdom Japan United States

In The Last Decade

Helen I. Field

28 papers receiving 2.3k citations

Peers

Countries citing papers authored by Helen I. Field

Since Specialization

Citations

This map shows the geographic impact of Helen I. Field's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen I. Field with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen I. Field more than expected).

Fields of papers citing papers by Helen I. Field

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen I. Field. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen I. Field. The network helps show where Helen I. Field may publish in the future.

Co-authorship network of co-authors of Helen I. Field

This figure shows the co-authorship network connecting the top 25 collaborators of Helen I. Field. A scholar is included among the top collaborators of Helen I. Field based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen I. Field. Helen I. Field is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An automated graphics tool for comparative genomics: the Coulson plot generator 2013 ·BMC Bioinformatics ·Helen I. Field,Richard Coulson,Mark C. Field	23
2	Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B 2012 ·Nature Communications ·Hyun‐Soo Cho,Tadahiro Shimazu,Gouji Toyokawa,Yataro Daigo,Yoshihiko Maehara,Shinya Hayami,Akihiro Ito,Ken Masuda,Noriko Ikawa,Helen I. Field,Eiju Tsuchiya,Shin‐ichi Ohnuma,Bruce A.J. Ponder,Minoru Yoshida,Yusuke Nakamura,Ryuji Hamamoto	98
3	The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 2011 ·Cancer Prevention Research ·Gouji Toyokawa,Hyun‐Soo Cho,Yukiko Iwai,Masanori Yoshimatsu,Masashi Takawa,Shinya Hayami,Kazuhiro Maejima,Noriaki Shimizu,Hirotoshi Tanaka,Tatsuhiko Tsunoda,Helen I. Field,John D. Kelly,David E. Neal,Bruce A.J. Ponder,Yoshihiko Maehara,Yusuke Nakamura,Ryuji Hamamoto	58
4	Enhanced Expression of EHMT2 Is Involved in the Proliferation of Cancer Cells through Negative Regulation of SIAH1 2011 ·Neoplasia ·Hyun‐Soo Cho,John D. Kelly,Shinya Hayami,Gouji Toyokawa,(unknown),Masanori Yoshimatsu,Tatsuhiko Tsunoda,Helen I. Field,David E. Neal,Bruce A.J. Ponder,Yusuke Nakamura,Ryuji Hamamoto	100
5	Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker 2011 ·Cancer Science ·Masashi Takawa,Ken Masuda,Masaki Kunizaki,Yataro Daigo,Katsunori Takagi,Yukiko Iwai,Hyun‐Soo Cho,Gouji Toyokawa,Yuka Yamane,Kazuhiro Maejima,Helen I. Field,Takaaki Kobayashi,Takayuki Akasu,Masanori Sugiyama,(unknown),Yutaka Atomi,Bruce A.J. Ponder,Yusuke Nakamura,Ryuji Hamamoto	158
6	Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer 2011 ·Molecular Cancer ·Gouji Toyokawa,Ken Masuda,Yataro Daigo,Hyun‐Soo Cho,Masanori Yoshimatsu,Masashi Takawa,Shinya Hayami,Kazuhiro Maejima,Makoto Chino,Helen I. Field,David E. Neal,Eiju Tsuchiya,Bruce A.J. Ponder,Yoshihiko Maehara,Yusuke Nakamura,Ryuji Hamamoto	96
7	Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt Pathway 2011 ·Neoplasia ·Gouji Toyokawa,Hyun‐Soo Cho,Ken Masuda,Yuka Yamane,Masanori Yoshimatsu,Shinya Hayami,Masashi Takawa,Yukiko Iwai,Yataro Daigo,Eiju Tsuchiya,Tatsuhiko Tsunoda,Helen I. Field,John D. Kelly,David E. Neal,Yoshihiko Maehara,Bruce A.J. Ponder,Yusuke Nakamura,Ryuji Hamamoto	84
8	The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G₁/S transition in cancer cells via transcriptional regulation of the HOXA1 gene 2011 ·International Journal of Cancer ·Hyun‐Soo Cho,Gouji Toyokawa,Yataro Daigo,Shinya Hayami,Ken Masuda,Noriko Ikawa,Yuka Yamane,Kazuhiro Maejima,Tatsuhiko Tsunoda,Helen I. Field,John D. Kelly,David E. Neal,Bruce A.J. Ponder,Yoshihiko Maehara,Yusuke Nakamura,Ryuji Hamamoto	76
9	Demethylation of RB Regulator MYPT1 by Histone Demethylase LSD1 Promotes Cell Cycle Progression in Cancer Cells 2010 ·Cancer Research ·Hyun‐Soo Cho,Takehiro Suzuki,Naoshi Dohmae,Shinya Hayami,Motoko Unoki,Masanori Yoshimatsu,Gouji Toyokawa,Masashi Takawa,Taiping Chen,Julia K. Kurash,Helen I. Field,Bruce A.J. Ponder,Yusuke Nakamura,Ryuji Hamamoto	172
10	Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers 2010 ·International Journal of Cancer ·Masanori Yoshimatsu,Gouji Toyokawa,Shinya Hayami,Motoko Unoki,Tatsuhiko Tsunoda,Helen I. Field,John D. Kelly,David E. Neal,Yoshihiko Maehara,Bruce A.J. Ponder,Yusuke Nakamura,Ryuji Hamamoto	239
11	Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers 2010 ·International Journal of Cancer ·Shinya Hayami,John D. Kelly,Hyun‐Soo Cho,Masanori Yoshimatsu,Motoko Unoki,Tatsuhiko Tsunoda,Helen I. Field,David E. Neal,Hiroki Yamaue,Bruce A.J. Ponder,Yusuke Nakamura,Ryuji Hamamoto	391
12	Seq4SNPs: new software for retrieval of multiple, accurately annotated DNA sequences, ready formatted for SNP assay design 2009 ·BMC Bioinformatics ·Helen I. Field,Serena Scollen,Craig Luccarini,Caroline Baynes,Jonathan J. Morrison,Alison M. Dunning,Douglas F. Easton,Paul D.P. Pharoah	4
13	Differential Endocytic Functions ofTrypanosoma brucei Rab5 Isoforms Reveal a Glycosylphosphatidylinositol-specific Endosomal Pathway 2002 ·Journal of Biological Chemistry ·Arun Pal,Belinda S. Hall,Darren Nesbeth,Helen I. Field,Mark C. Field	77
14	Cell-cycle and developmental regulation of TbRAB31 localisation, a GTP-locked Rab protein from Trypanosoma brucei 2000 ·Molecular and Biochemical Parasitology ·Helen I. Field,Trevor Sherwin,(unknown),Keith Gull,Mark C. Field	59
15	Complexity of Trypanosomatid Endocytosis Pathways Revealed by Rab4 and Rab5 Isoforms in Trypanosoma brucei 1998 ·Journal of Biological Chemistry ·Helen I. Field,Mariam Farjah,Arun Pal,Keith Gull,Mark C. Field	77
16	Tandem Duplication of rab Genes Followed by Sequence Divergence and Acquisition of Distinct Functions in Trypanosoma brucei 1997 ·Journal of Biological Chemistry ·Helen I. Field,Mark C. Field	71
17	Leptomonas seymouri, Trypanosoma brucei:A Method for Isolating Trypanosomatid Nuclear Factors Which BindT. bruceiSingle-Stranded g-Rich Telomere Sequence 1996 ·Experimental Parasitology ·Helen I. Field,Mark C. Field	10
18	Characterisation of protein isoprenylation in procyclic form Trypanosoma brucei 1996 ·Molecular and Biochemical Parasitology ·Helen I. Field,Ian Blench,Simon L. Croft,Mark C. Field	33
19	A homologue of the nuclear GTPase Ran/TC4 from Trypanosoma brucei 1995 ·Molecular and Biochemical Parasitology ·Mark C. Field,Helen I. Field,John C. Boothroyd	21
20	Cloning, sequencing, and demonstration of polymorphism in trypanothione reductase from Crithidia fasciculata 1992 ·Molecular and Biochemical Parasitology ·Helen I. Field,Anthony Cerami,Graeme B. Henderson	18

About Helen I. Field

Helen I. Field is a scholar working on Physiology, Transplantation and Cell Biology, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Trypanosoma species research and implications (10 papers) and Cancer-related gene regulation (9 papers). The work is most often cited by research in Physiology (132 citations), Molecular Biology (1.9k citations) and Cancer Research (285 citations). Helen I. Field has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Ryuji Hamamoto, Yusuke Nakamura, Shinya Hayami, Mark C. Field, Bruce A.J. Ponder, Masanori Yoshimatsu, David E. Neal, Tatsuhiko Tsunoda, Hyun‐Soo Cho and John D. Kelly. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact